ISGylation controls exosome secretion by promoting lysosomal degradation of MVB proteins.

Villarroya-Beltri C, Baixauli F, Mittelbrunn M, Fernández-Delgado I, Torralba D, Moreno-Gonzalo O, Baldanta S, Enrich C, Guerra S, Sánchez-Madrid F. · 2016

Read ISGylation controls exosome secretion by promoting lysosomal degradation of MVB proteins. by Villarroya-Beltri C, Baixauli F, Mittelbrunn M, Fernández-Delgado I, Torralba D, Moreno-Gonzalo O, Baldanta S, Enrich C, Guerra S, Sánchez-Madrid F. (2016) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc5123068.txt.

Introduction

Carolina Villarroya-Beltri and nine co-authors found a switch controlling exosome release, reporting in Nature Communications in 2016. Villarroya-Beltri leads with her first surname, as the byline prints it hyphenated. Exosomes are vesicles cells send out for communication, formed inside compartments called multivesicular bodies that can either release them or dump them for destruction.

The team showed that a tag called ISGylation, added during antiviral defense, pushes those compartments toward destruction. Switching the tag on lowered compartment counts and cut exosome release in cells and mice. The tag marks compartment proteins, including TSG101, for clumping and breakdown in lysosomes; blocking that breakdown restored release. The finding adds a new control point over how much exosome traffic a cell produces.

Catalog record

CREATORVillarroya-Beltri C, Baixauli F, Mittelbrunn M, Fernández-Delgado I, Torralba D, Moreno-Gonzalo O, Baldanta S, Enrich C, Guerra S, Sánchez-Madrid F.
YEAR2016
COLLECTIONPAPERS
FORMATTXT
FILE SIZE58 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC5123068

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

ISGylation controls exosome secretion by promoting lysosomal degradation of MVB proteins By Carolina Villarroya-Beltri, Francesc Baixauli, María Mittelbrunn, Irene Fernández-Delgado, Daniel Torralba, Olga Moreno-Gonzalo, Sara Baldanta, Carlos Enrich, Susana Guerra, Francisco Sánchez-Madrid Published in: Nature Communications DOI: 10.1038/ncomms13588 ABSTRACT Abstract Exosomes are vesicles secreted to the extracellular environment through fusion with the plasma membrane of specific endosomes called multivesicular bodies (MVB) and mediate cell-to-cell communication in many biological processes. Posttranslational modifications are involved in the sorting of specific proteins into exosomes. Here we identify ISGylation as a ubiquitin-like modification that controls exosome release. ISGylation induction decreases MVB numbers and impairs exosome secretion. Using ISG15-knockout mice and mice expressing the enzymatically inactive form of the de-ISGylase USP18, we demonstrate in vitro and in vivo that ISG15 conjugation regulates exosome secretion. ISG15 conjugation triggers MVB co-localization with lysosomes and promotes the aggregation and degradation of MVB proteins. Accordingly, inhibition of lysosomal function or autophagy restores exosome secretion. Specifically, ISGylation of the MVB protein TSG101 induces its aggregation and degradation, being sufficient to impair exosome secretion. These results identify ISGylation as a novel ubiquitin-like modifier in the control of exosome production. Exosomes are vesicles secreted to the extracellular environment by most cell types. They are key mediators of cell-to-cell communication in many different contexts, including the immune response1,2 and tumour progression3,4. Exosomes originate in endosomal compartments called multivesicular bodies (MVBs), which are late endosomes containing multiple intraluminal vesicles (ILVs) formed by the invagination of the endosomal membrane. When MVBs fuse with the plasma membrane, ILVs are released as exosomes5. Alternatively, MVBs can fuse with the lysosomal compartment, resulting in degradation of their content. Exosome composition is not a mere copy of cytosolic content; rather, specific proteins and nucleic acids are selectively sorted into exosomes. The amount and content of exosomes can moreover change in response to different stimuli6,7. Such changes in exosome composition determine the final outcome of exosome-mediated communication8,9. The mechanisms that control exosome composition and content are still not well understood10. Posttranslational modifications such as ubiquitination may play an important role in the sorting of proteins into exosomes11,12,13. The endosomal sorting complex required for transport (ESCRT) recognizes ubiquitinated proteins and sorts them into ILVs14. The ESCRT complex is essential for the sorting of proteins such as epidermal growth factor receptor into MVBs that are degraded through fusion with lysosomes15, but is also involved in the regulation of exosome composition and secretion16,17. Another ubiquitin-like protein (UBL) that can modify exosomal proteins is SUMO, whose conjugation to hnRNPA2B1 is essential for the sorting of microRNAs into exosomes18, and enhances the secretion of α-synuclein into extracellular vesicles (EVs) in an ESCRT-dependent manner19. ISG15 is an interferon (IFN)-α/β-induced UBL20, which exerts its functions in two distinct states: as a free molecule (intracellular and extracellular)21 or conjugated to target proteins (ISGylation)22,23. Analogous to ubiquitin, ISG15 conjugation is mediated by the consecutive action of an E1-activating enzyme (Ube1L), an E2-conjugating enzyme (UbCH8) and E3 ligases (mHERC6/hHERC5)24,25,26, and counteracted by the specific isopeptidase USP18 (ref. 27). ISGylation was shown to occur in a co-translational process favouring modification of viral proteins in infected cells, which, in turn, interferes with virus assembly or function28,29,30. Furthermore, cellular proteins involved in antiviral defense or export of viral particles have been shown to be ISGylated, supporting the antiviral function of ISG15 (ref. 28). Studies in mice have demonstrated a role for ISG15 in antiviral immunity. Hence, mice lacking ISG15 exhibit a higher susceptibility to several pathogens including virus31 and bacteria32, and this is reverted in USP18-mutant mice, in which high levels of ISG15 conjugation are observed33. However, human ISG15 seems to have critical immune functions but not in antiviral immunity; unlike mice, ISG15 deficiency increased viral resistance in humans34. Specifically, free extracellular human ISG15 is important in IFN-γ-dependent anti-mycobacterial immunity21, whereas free intracellular ISG15 is involved in USP18-mediated downregulation of IFN-α/β signalling35. ISG15 expression blocks the process of virus-budding by different mechanisms such as the blockage of ESCRT machinery in HIV-infected cells36, or in the case of Ebola and other enveloped virus infections, inhibiting the Nedd4 E3 ubiquitin ligase37. Interestingly, exosomes and viruses share many features, and some viruses have been shown to exploit exosome and microvesicle secretion pathways38,39. In addition, exosomes are enriched in ISGylation targets, such as TSG101 (ref. 40) and heat-shock proteins41. Here we show that IFN-I inhibits exosome secretion by inducing protein ISGylation. We demonstrate that the ISGylation of the MVB protein TSG101 induces its aggregation and degradation, and this is sufficient for impairing exosome secretion. Moreover, the ISGylation-induced defect in exosome secretion is rescued on inhibition of lysosomal function or autophagy. RESULTS ISGylation inhibits exosome secretion To analyse the role of ISGylation on exosome production, we first treated Jurkat T cells with IFN-I, to induce ISG15 expression and conjugation (Supplementary Fig. 1A), and purified the secreted EVs from their culture supernatants by a serial ultracentrifugation protocol. IFN-I treatment inhibited the secretion of the classical exosome markers CD63, TSG101 and CD81 in the purified EVs (Fig. 1a). A concomitant decrease in the exosomal markers on IFN-I treatment was also observed after an additional purification step by ultracentrifugation in a sucrose gradient (Supplementary Fig. 1B). Interestingly, the few EVs secreted by IFN-treated cells were recovered in different fractions than the EVs from non-treated cells, suggesting that they might be of different nature. To further investigate the function of ISGylation in controlling EVs secretion, we next overexpressed ISG15 and the machinery responsible for ISGylation (E1, E2 and E3) in HEK293 cells, which mimics the activation of the ISG15 pathway (Supplementary Fig. 1A)24,28 without activating other pathways induced by IFN-I treatment. ISGylation induction inhibited the secretion of EVs containing CD63, TSG101 and CD81 (Fig. 1b). To dissect whether the inhibition in exosomal markers secretion was due to ISG15 overexpression itself or to increased ISG15 conjugation to proteins, we overexpressed the ISGylation machinery together with an ISG15 mutated at the carboxy-terminal (ISG15MUT), thus disabling protein conjugation. Cells overexpressing ISG15MUT showed higher levels of exosomal markers in comparison with ISG15WT (Fig. 1c), demonstrating that ISG15 conjugation to proteins, but not free ISG15, is required for the inhibition of exosomal markers secretion. Nanoparticle tracking analysis (NTA) showed a decrease in the number of particles secreted on ISG15WT overexpression in comparison with ISG15MUT-expressing cells (Supplementary Fig. 1C), indicating that ISGylation is not causing a mere decrease in the sorting of exosomal markers in EVs, but an actual decrease in exosome secretion. However, NTA did not reveal any significant decrease in the secretion of nanoparticles on IFN-I treatment (Supplementary Fig. 1D). [Figure: ISGylation inhibits exosome secretion.(a) Western blot analysis of EVs purified by serial ultracentrifugation from cell culture supernatants from equal numbers of Jurkat T cells untreated (Cont) or treated with 1,000 U ml−1 IFN-I for 16 h. Cells and EVs (Exo) were blotted for the exosomal markers CD63, TSG101, Flotillin and CD81, and for the endoplasmic reticulum marker Calnexin. Right graph: quantification of exosomal protein levels in the EVs obtained from IFN-I-treated and untreated cells in three independent experiments. (b) Western blot analysis of the EVs obtained from equal numbers of untransfected HEK293 cells (Cont) or co-transfected with ISG15 and the ISGylation machinery; E1, E2, E3 ligases (ISG15). Cells and EVs (Exo) were blotted for CD63,

Read the complete text